iBio (IBIO) Gains from Investment Securities (2018 - 2025)

iBio (IBIO) has disclosed Gains from Investment Securities for 12 consecutive years, with $53000.0 as the latest value for Q3 2025.

  • Quarterly Gains from Investment Securities fell 26.39% to $53000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $203000.0 through Dec 2025, up 2288.24% year-over-year, with the annual reading at $47500.0 for FY2024, 224.94% up from the prior year.
  • Gains from Investment Securities for Q3 2025 was $53000.0 at iBio, down from $78000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $32.0 million in Q1 2021, with the low at $2500.0 in Q1 2023.
  • Average Gains from Investment Securities over 5 years is $2.3 million, with a median of $69000.0 recorded in 2023.
  • Peak annual rise in Gains from Investment Securities hit 3569.72% in 2022, while the deepest fall reached 99.92% in 2022.
  • Over 5 years, Gains from Investment Securities stood at $34880.0 in 2021, then skyrocketed by 3569.72% to $1.3 million in 2022, then tumbled by 94.77% to $67000.0 in 2023, then tumbled by 87.31% to $8500.0 in 2024, then soared by 523.53% to $53000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $53000.0, $78000.0, and $84700.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.